Eberhardt, W. E. E., & Thomas, M. (2014). Feasibility of adding everolimus to carboplatin and paclitaxel, with or without bevacizumab, for treatment-naive, advanced non-small cell lung cancer. Investigational new drugs, 32(1), . https://doi.org/10.1007/s10637-013-9958-3
Chicago-Zitierstil (17. Ausg.)Eberhardt, Wilfried E. E., und Michael Thomas. "Feasibility of Adding Everolimus to Carboplatin and Paclitaxel, with or Without Bevacizumab, for Treatment-naive, Advanced Non-small Cell Lung Cancer." Investigational New Drugs 32, no. 1 (2014). https://doi.org/10.1007/s10637-013-9958-3.
MLA-Zitierstil (9. Ausg.)Eberhardt, Wilfried E. E., und Michael Thomas. "Feasibility of Adding Everolimus to Carboplatin and Paclitaxel, with or Without Bevacizumab, for Treatment-naive, Advanced Non-small Cell Lung Cancer." Investigational New Drugs, vol. 32, no. 1, 2014, https://doi.org/10.1007/s10637-013-9958-3.